Patent details

LUC00350 Product Name: Adagrasib ou un sel pharmaceutiquement acceptable de celui-ci

Basic Information

Publication number:
LUC00350
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP188794846
Legal Status:
Pending & Published
Application number:
LUC00350
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/23/1744
Marketing Authorization Type:
Marketing Authorization Date:
09/01/2024
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
13/06/2024
First Marketing Authorization date:
09/01/2024
Grant date:
Activation date:
Publication date:
13/06/2024
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
09/01/2039
SPC Extension Expiration:
09/01/2039
Rejection date:
Withdrawal date:

Owner

From:
13/11/2024
 
 

Name:
MIRATI THERAPEUTICS, INC.
Address:
Route 206 and Province Line Road, 08543, Princeton, New Jersey, United States (US)

From:
13/06/2024
 
 

Name:
Array Biopharma Inc.
Address:
3200 Walnut Street, Boulder, CO 80301, United States (US)

History of Owners

From:
13/11/2024
To:
13/11/2024

Name:
MIRATI THERAPEUTICS, INC.
Address:
3545 Cray Court, CA 92121, San Diego, United States (US)

From:
13/06/2024
To:
13/11/2024

Name:
Mirati Therapeutics, Inc.
Address:
9393 Towne Centre Drive Suite 200, San Diego, CA 92121, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
13/06/2024
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
CO
Bulletin edition number:
2024/14
Publication date:
06/12/2024
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:
CO
Bulletin edition number:
2024/14
Publication date:
06/12/2024
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

3

Bulletin Heading:
SPC1
Bulletin edition number:
2024/09
Publication date:
11/07/2024
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20240000467A
Date Registered:
13/11/2024
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

1

Name:
Array Biopharma Inc.
Address:
3200 Walnut Street, Boulder, CO 80301, United States (US)

2

Name:
MIRATI THERAPEUTICS, INC.
Address:
3545 Cray Court, CA 92121, San Diego, United States (US)

Removed Pledgee

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20240000469A
Date Registered:
13/11/2024
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

1

Name:
Array Biopharma Inc.
Address:
3200 Walnut Street, Boulder, CO 80301, United States (US)

2

Name:
MIRATI THERAPEUTICS, INC.
Address:
Route 206 and Province Line Road, 08543, Princeton, New Jersey, United States (US)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
30/11/2038
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
13/06/2024 Application Form 3
13/06/2024 Marketing authorization 3
13/06/2024 Summary of the product caracteristics 32
13/06/2024 MA publication 8
13/06/2024 Outgoing Correspondence 1
13/06/2024 Publication 1
13/11/2024 Request For Change 1
14/11/2024 Outgoing Correspondence 1
13/11/2024 Request For Change 1
14/11/2024 Outgoing Correspondence 1